Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza

2020839 citationsJournal Articlebronze Open Access

Authors

Silan Gu · State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Yanfei Chen · State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Zhengjie Wu · State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Yunbo Chen · Zhejiang University

Hainv Gao · Zhejiang Shuren University

Longxian Lv · State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Abstract

The gut microbial signature of patients with COVID-19 was different from that of H1N1 patients and HCs. Our study suggests the potential value of the gut microbiota as a diagnostic biomarker and therapeutic target for COVID-19, but further validation is needed.

Topics & Keywords

Gut microbiota and health Clostridium difficile and Clostridium perfringens research Helicobacter pylori-related gastroenterology studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 71, Issue 10, pp. 2669-2678

DOI: 10.1093/cid/ciaa709

Field-Weighted Citation Impact: 53.37